sample

AbstractBACKGROUND:Recurrence patterns in stage III colon cancer (CC) patients according to molecular markers remain...

Posté par : Dr. Dewi VERNEREY,
Nom de la revue : Ann Surg Oncol.

sample

AbstractBackgroundNivolumab-ipilimumab demonstrated a survival benefit over sunitinib in first-line setting for...

Posté par : ,
Nom de la revue : European Journal of Cancer

2015-2024 © Copyright - UMQVC.org

Website by Pearlweb